Stockreport

Co-Diagnostics Expects New Royalty Structure to Lift Revenue and Expand Customer Base  

Co-Diagnostics, Inc.  (CODX) 
US:NASDAQ Investor Relations: ir.codiagnostics.com/investor-relations
PDF New York City, NY, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Analysts for Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a patented diagnostic test [Read more]